Bitterman Kevin sold IRON
September 2, 2026 · Form 4 insider transaction
Bitterman Kevin sold 9 shares of Disc Medicine, Inc. at $80.98 per share, a transaction worth $728.82. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.9677 to $81.0079 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.; These shares are held by Atlas Venture Opportunity Fund II, L.P. ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, L.P. ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any.